Need all Congresses? Press Enter for expanded federal results.

Drug safety, medical device, and laboratory regulation

Track this topic across federal Congress bills, then open each bill page for full context and activity.

Matched bills
305
Coverage
110th-119th
Current view
116th Congress
Congress Filter
Switch views to focus this topic by Congress.
Bills In This Topic
305 results.
Click any row to open the federal bill page.
Bill Title Congress Status Action Date
HR 5333
Ensuring Patient Access to Critical Breakthrough Products Act of 2019
116th Referred to the Subcommittee on Health. December 9, 2019
HR 5279
Cosmetic Safety Enhancement Act of 2019
116th Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote . March 11, 2020
HR 5216
Quality Care for Nursing Home Residents Act of 2019
116th Referred to the Subcommittee on Health. November 22, 2019
HR 5198
Patients’ Right to Know Their Medication Act of 2019
116th Referred to the Subcommittee on Health. November 21, 2019
HR 5141
Humane Cosmetics Act of 2019
116th Referred to the Subcommittee on Health. November 19, 2019
HR 5133
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
116th Placed on the Union Calendar, Calendar No. 578. December 24, 2020
HR 5031
Medical Innovation Act of 2019
116th Referred to the Subcommittee on Health. November 12, 2019
HR 4974
MATE Act of 2019
116th Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. December 18, 2019
HR 4955
Protecting Access to Safe and Effective Medicines Act of 2019
116th Referred to the Subcommittee on Health. November 1, 2019
HR 4906
Insulin Price Reduction Act
116th Referred to the Subcommittee on Health. October 30, 2019
HR 4866
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020
116th Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. September 22, 2020
HR 4742
Protecting American Lungs Act of 2019
116th Placed on the Union Calendar, Calendar No. 322. February 21, 2020
HR 4712
Fairness in Orphan Drug Exclusivity Act
116th Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. November 18, 2020
HR 4710
Pharmaceutical Independence Long-Term Readiness Reform Act
116th Referred to the Subcommittee on Health. November 8, 2019
HR 4667
Biomedical Innovation Expansion Act of 2019
116th Referred to the Subcommittee on Health. October 14, 2019
HR 4640
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019
116th Referred to the Subcommittee on Health. October 14, 2019
HR 4633
Investing in Safety and Innovation Act of 2019
116th Referred to the Subcommittee on Health. October 14, 2019
HR 4624
END ENDS Act of 2019
116th Referred to the Subcommittee on Health. October 9, 2019
HR 4553
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act
116th Referred to the Subcommittee on Health. September 30, 2019
HR 4460
Turn the Tide Act
116th Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. October 28, 2019
HR 4439
Creating Hope Reauthorization Act
116th Received in the Senate. September 30, 2020
HR 4404
Depression Side Effect Labeling Awareness Act of 2019
116th Referred to the Subcommittee on Health. September 20, 2019
HR 4400
Advancing Education on Biosimilars Act of 2019
116th Referred to the Subcommittee on Health. September 20, 2019
HR 4399
SAVE Moms and Babies Act of 2019
116th Referred to the Subcommittee on Health. September 20, 2019
HR 4398
Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
116th Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. October 2, 2019
HR 4322
Expanding Cannabis Research and Information Act
116th Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. October 2, 2019
HR 4244
MAGIC Act
116th Referred to the Subcommittee on Health. September 10, 2019
HR 4106
Responsibility in Drug Advertising Act of 2019
116th Referred to the Subcommittee on Health. July 31, 2019
HR 4100
DISARM Act of 2019
116th Referred to the Subcommittee on Health. July 31, 2019
HR 3947
Competition Prescription Act of 2019
116th Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties. August 28, 2019
HR 3929
GAIN Act
116th Referred to the Subcommittee on Consumer Protection and Commerce. July 25, 2019
HR 3812
REMEDY Act
116th Referred to the Subcommittee on Health. July 18, 2019
HR 3797
Medical Marijuana Research Act
116th Read twice and referred to the Committee on the Judiciary. December 18, 2020
HR 3737
Foreign Manufacturers Legal Accountability Act of 2019
116th Referred to the Subcommittee on Livestock and Foreign Agriculture. August 9, 2019
HR 3656
ACCESS Act of 2019
116th Referred to the Subcommittee on Health. July 10, 2019
HR 3584
LAB Act
116th Referred to the Subcommittee on Health. June 28, 2019
HR 3573
CCM–CARE Act
116th Referred to the Subcommittee on Health. June 28, 2019
HR 3496
CREATE Opportunities Act
116th Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. July 30, 2019
HR 3443
To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug appl...
116th Sponsor introductory remarks on measure. (CR E971) July 24, 2019
HR 3379
PRICED Act
116th Referred to the Subcommittee on Health. June 21, 2019